Company Quick10K Filing
Therapix Biosciences
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 0 $0
20-F 2018-12-31 Annual: 2018-12-31
20-F 2017-12-31 Annual: 2017-12-31
20-F 2016-12-31 Annual: 2016-12-31

Therapix Biosciences Financials

-

TRPX Metrics, Comps, Filings


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Quarter)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
Advaxis (ADXS) 5,775 56,133 6,864 22,012 0 1,812 3,429 -35,980
Tonix Pharmaceuticals Holding (TNXP) 8,683 15,008 2,186 0 0 -23,639 -23,595 -3,567
Delmar Pharmaceuticals (DMPI) 3,296 4,037 2,070 0 0 8,048 8,048 -423
Diffusion Pharmaceuticals (DFFN) 1,924 18,929 2,752 0 0 -17,534 -17,962 -6,448
Phibro Animal Health (PAHC) 1,272 726,671 510,656 624,112 264,624 54,713 109,193 174,989
OHR Pharmaceutical (OHRP) 10,129 8,693 752 0 0 -9,529 -8,750 8,704
Therapix Biosciences (TRPX) 0 4,560 0 0 0 0 -1,518
Grifols (GRFS) 12,477,046 7,780,442 0 0 0 0 -592,178
Novo Nordisk (NVO)
Bioblast Pharma (ORPN) 39,270 11,034 1,328 0 0 -3,073 -3,073 29,534
Trillium Therapeutics (TRIL) 55,459 13,858 0 0 0 0 -0
Kiniksa Pharmaceuticals (KNSA) 308,137 32,940 0 0 -169,998 -170,154 -287,447
AstraZeneca (AZN) 60,651,000 46,607,000 0 0 0 0 -893,000
Immtech Pharmaceuticals (IMMP)
Zomedica Pharmaceuticals (ZOM) 9,479 1,797 0 0 -24,413 -24,124 -5,822
VTV Therapeutics (VTVT) 9,072 21,914 10,646 0 -6,924 -4,119 5,935
Nabriva Therapeutics (NBRV) 678,758 83,645 40,240 3,486 0 -125,573 -123,455 629,164
Affimed (AFMD) 116,174 0 0 0 0 -0
Zealand Pharma (ZEAL)
Intec Pharma (NTEC) 46,860 11,751 0 0 -20,665 -20,593 -20,796

Balance Sheet ($'000)2017-12-312018-12-31
Cash9,2191,518
Accounts Receivable
Inventory
PP&E
Assets9,5664,560
Accounts Payable
Long-Term Debt
Liabilities
Stockholders' Equity
Income Statement ($'000)2017-12-312018-12-31
Revenue
Cost of Revenue
Gross Profit
R&D
SG&A
Tax
Net Income
Cash Flow ($'000)2017-12-312018-12-31
Cash Operating
Cash Investing
Cash Financing